REQUEST A DEMO
Total
USD $0.00
Search more companies

Hoe Pharmaceuticals Sdn. Bhd. (Malaysia)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Hoe Pharmaceuticals Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

HOE Pharmaceuticals Sdn. Bhd., is a subsidiary of Taisho Pharmaceutical, a Japanese MNC. The company develops, manufactures, and markets dermatological products. With a focus on exports to over 20 countries, HOE Pharmaceuticals Sdn. Bhd. aims to be a global supplier in the dermatological products industry.

Headquarters
B-3A-07, Dataran 32, No. 2, Jalan 19/1
Petaling Jaya; Selangor; Postal Code: 46300

Contact Details: Purchase the Hoe Pharmaceuticals Sdn. Bhd. report to view the information.

Website: http://www.hoepharma.com.my

Basic Information
Total Employees:
Purchase the Hoe Pharmaceuticals Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Hoe Pharmaceuticals Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Hoe Pharmaceuticals Sdn. Bhd. report to view the information.
Incorporation Date:
February 06, 1979
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Hoe Pharmaceuticals Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
6.2%
Total operating revenue
6.2%
Operating Profit/Loss (EBIT)
1.33%
EBITDA
-5.07%
Net Profit/Loss for the Period
1.67%
Total Assets
-3.15%
Total Equity
-6.05%
Operating Profit Margin (ROS)
-1.07%
Net Profit Margin
-0.75%
Return on Equity (ROE)
2.26%
Quick Ratio
-0.41%
Cash Ratio
-0.69%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?